LIGAND PHARMACEUTICALS INCORPORATED - COMMON STOCK

Company

LIGAND PHARMACEUTICALS INC

Filed

February 13, 2004

Accession Number

0000931921-04-000010

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →